Immunogenicity of third dose COVID-19 vaccine strategies in patients who are immunoco
 

Immunogenicity of third dose COVID-19 vaccine strategies in patients who are immunocompromised with suboptimal immunity following two doses (OCTAVE-DUO): an open-label, multicentre, randomised, controlled, phase 3 trial

https://www.thelancet.com/journals/l...065-1/fulltext


Here's Yet Another Reason to Stay on Top of Your COVID Vaccine Boosters

https://www.sciencealert.com/heres-y...ccine-boosters

"...If the effects don't fade too rapidly, new data suggests regular COVID-19 vaccinations could strengthen our immune systems against future variants and even related viruses. This is on top of the proven protection they already provide against current infections..."